Despite a plaintiff’s argument that upholding the dismissal of the first hormone replacement therapy tort case to reach Pennsylvania’s highest court conflicts with succeeding case law in Pennsylvania’s HRT litigation, the state Supreme Court is leaving intact a judgment notwithstanding the verdict in favor of drugmaker Wyeth.

A per curiam order was entered by the Supreme Court last month in response to the plaintiff’s petition for reconsideration in Nelson v. Wyeth. The Supreme Court first denied the plaintiff’s petition for allowance of appeal March 30.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]